Demonstrated results for intravascular imaging
Class IA
Leading societies recommend IVUS-guided PCI in patients with ACS
Intravascular imaging is now a Class IA recommendation from ACC/AHA/ACEP/NAEMSP/SCAI for patients with Acute Coronary Syndrome (ACS) to optimize clinical outcomes.
74%
of the time, IVUS use resulted in a change in PCI strategy [1]
In ADAPT-DES, the largest study of IVUS use to date, IVUS guidance was associated with a reduction in stent thrombosis, myocardial infarction, and major adverse cardiac events within 1 year after DES implantation. [1]
36%
relative risk reduction in TVF at 1 year when intravascular imaging was used [2]
Among patients with complex coronary-artery lesions, intravascular imaging-guided PCI led to a lower risk of a composite of death from cardiac causes, target-vessel-related myocardial infarction, or clinically driven target-vessel revascularization than angiography-guided PCI [2].
44%
lower risk of cardiac death associated with IVUS [3]
Compared with angiography guidance, intravascular imaging guidance of coronary stent implantation with OCT or intravascular ultrasound enhances both the safety and effectiveness of PCI, reducing the risks of death, myocardial infarction, repeat revascularisation, and stent thrombosis [3].